SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Prospector who wrote (2731)7/7/1998 7:41:00 PM
From: Gwolf  Read Replies (3) of 5402
 
I personally went down a laundry list of potential competitors that could come out with a similar product. In each case Dr. Drees knew of each situation, who was behind it and their current status. I should mention that these are not the drug we have been talking about on this thread. Thanks to the good work of Chirodoc I went through each University, research facility and foreign government that had any interest in just the Flurocarbon based product. In each case those mentioned are not any where close to bringing a product to the stage that SGNC is. In most cases it was medical people who have been researching Flurocarbons for various uses but not with the intention of developing a product.

Dr.Drees enlightened us to the fact that this product has over 150 uses, take for example how it can be used in cancer therapies. By introducing oxygen through PHER-02 you oxygenate a tumor so that radiation or Chemotherapies therapeutic effects are multiplied, thereby making it more effective. I had thought that this product was for transfusions only - it isn't. It can be used for oxygenating the skin tissues of burn victims. There are many more uses that he didn't go into. Obviously we are looking at more than the $20 billion market that we originally were told about, how big is the market for the other uses, I don't know but do intend to call Dr. Drees and ask him more questions about these additional applications.

There were several of us that stayed after the meeting and asked him additional questions, unfortunately he had a flight to catch or we probably could have carried on with questions for some time. The questions that you folks sent to Prospector are in his hands and he will be responding to them.

Gwolf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News